Scientists probe nose immunity in vulnerable patients
NCT ID NCT07295535
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This observational study will compare nasal immune responses to respiratory viruses like SARS-CoV-2 in 40 adults, including immunocompromised patients and healthy volunteers. Researchers aim to understand how underlying conditions and treatments affect immune cell activity in the nose. The study does not test any treatment but may guide future vaccine or therapy strategies.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could help researchers understand how immune system weaknesses affect protection against respiratory viruses like COVID-19.
- What could go wrong
- This is a small observational study, not a treatment trial. It may not lead to direct medical advances, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY SUBJECTS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Fondazione IRCCS Policlinico San Matteo di Pavia
RECRUITINGPavia, Pavia, 27100, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Radioactive tracer reveals the Body's journey of an experimental drug
- Can music lessons rewire Teens' social media habits?
- Can a Finger-Prick replace the lab draw? a device puts accuracy to the test
- Avocado at breakfast: a secret weapon for blood sugar and fullness?
- Sound waves as medicine: ultrasound may tame inflammation without drugs
- Broader pneumonia shield: new vaccine tested in children